0000899243-16-011568.txt : 20160112 0000899243-16-011568.hdr.sgml : 20160112 20160112174532 ACCESSION NUMBER: 0000899243-16-011568 CONFORMED SUBMISSION TYPE: 4 PUBLIC DOCUMENT COUNT: 1 CONFORMED PERIOD OF REPORT: 20160111 FILED AS OF DATE: 20160112 DATE AS OF CHANGE: 20160112 ISSUER: COMPANY DATA: COMPANY CONFORMED NAME: Aldeyra Therapeutics, Inc. CENTRAL INDEX KEY: 0001341235 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 STATE OF INCORPORATION: DE FISCAL YEAR END: 1231 BUSINESS ADDRESS: STREET 1: 131 HARTWELL AVENUE STREET 2: SUITE 320 CITY: LEXINGTON STATE: MA ZIP: 02421 BUSINESS PHONE: 781-761-4904 MAIL ADDRESS: STREET 1: 131 HARTWELL AVENUE STREET 2: SUITE 320 CITY: LEXINGTON STATE: MA ZIP: 02421 FORMER COMPANY: FORMER CONFORMED NAME: Aldexa Therapeutics, Inc. DATE OF NAME CHANGE: 20130102 FORMER COMPANY: FORMER CONFORMED NAME: Neuron Systems Inc DATE OF NAME CHANGE: 20051012 REPORTING-OWNER: OWNER DATA: COMPANY CONFORMED NAME: Clark David J CENTRAL INDEX KEY: 0001662693 FILING VALUES: FORM TYPE: 4 SEC ACT: 1934 Act SEC FILE NUMBER: 001-36332 FILM NUMBER: 161339566 MAIL ADDRESS: STREET 1: 131 HARTWELL AVE CITY: LEXINGTON STATE: MA ZIP: 02421 4 1 doc4.xml FORM 4 SUBMISSION X0306 4 2016-01-11 0 0001341235 Aldeyra Therapeutics, Inc. ALDX 0001662693 Clark David J C/O ALDEYRA THERAPEUTICS, INC. 131 HARTWELL AVENUE, SUITE 320 LEXINGTON MA 02421 0 1 0 0 Chief Medical Officer Employee Stock Option (Right to Buy) 6.76 2016-01-11 4 A 0 100000 0.00 A 2026-01-11 Common Stock 100000 100000 D 25% of the shares shall vest after 12 months of continuous service with the Issuer, the balance will vest in equal monthly installments over the next 36 months of continuous service with the Issuer. /s/ David J. Clark 2016-01-12